COMPANY OVERVIEW

Grid Therapeutics is an emerging biotechnology company whose research and development efforts are in the area of cancer therapeutics, applying an innovative platform to develop human derived antibodies against novel targets.

---

LOCATION

Durham, NC, USA

---

THERAPEUTIC AREAS

Oncology

---

WEBSITE

https://gridtherapeutics.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Nov 3, 2022

Grid Therapeutics Announces Upcoming Scientific Presentation at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting

Jun 24, 2020

Grid Therapeutics Announces Enrollment of First Patient in Phase 1 Study of GT103 in Refractory NSCLC Patients

Apr 14, 2020

Grid Therapeutics Announces FDA Approval of IND Application for GT103

Apr 18, 2018

Grid Therapeutics Closes Series B Financing

Sep 14, 2017

Grid Therapeutics Closes Series A Financing

For More Press Releases

---